The FDA has cleared the first app that integrates glucose data with multiple daily injection (MDI) insulin dosing for people with diabetes.

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced ...

The FDA has granted 510(k) clearance to Medtronic for its MiniMed “Go Smart” multiple daily injection system — the first ...

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

Here’s what the science says.

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

Sun Pharma receives DCGI approval to launch generic semaglutide injection, Noveltreat, for weight management in India.

Researchers from Kumamoto University have developed a new peptide-based technology that enables insulin—normally injected—to be taken orally while still powerfully lowering blood sugar. Their ...

In 2018, Health Canada authorized semaglutide injections — more famously known by the brand name Ozempic — for blood sugar ...